收藏切换
Mitochondrial retrograde signaling: a new option for the treatment of mitochondrially related diseases
收藏切换
PDF
Yu JIANG, Shou-bao WANG*, Guan-hua DU*
Acta Pharmaceutica Sinica | 2021, 56(3) : 661 - 668
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(3): 661-668
Reviews
Mitochondrial retrograde signaling: a new option for the treatment of mitochondrially related diseases
Full
Yu JIANG, Shou-bao WANG*, Guan-hua DU*
Affiliations
  • Beijing Key Lab of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2021-03-12 doi: 10.16438/j.0513-4870.2020-1633
Outline
收藏切换

Mitochondria play a key role in cell metabolism. In addition to synthesizing ATP, they also participate in many physiological and pathological processes, including apoptosis, inflammation, oxidative stress, neuronal disease, tumor development, and aging. Most gene transcription of mitochondrial proteins occurs in the nucleus, so the biogenesis of mitochondria and the maintenance of mitochondrial homeostasis mainly depend on the expression of nuclear genes (nDNA) and mitochondria-nucleus interactions. Conversely, mitochondria can affect the expression of nuclear genes through nuclear transcription factors, a process called mitochondrial retrograde signaling. This review summarizes the research progress on mitochondria-nucleus retrograde signaling and its regulation, including the ways by which mitochondria regulate nuclear genes and affect biological processes, and discusses new strategies for the treatment of diseases that involve mitochondrial retrograde signaling in disease pathology.

nuclear genome  /  mitochondrial genome  /  mitochondria-nucleus communication  /  mitochondrial retrograde signal
Yu JIANG, Shou-bao WANG, Guan-hua DU. Mitochondrial retrograde signaling: a new option for the treatment of mitochondrially related diseases[J]. Acta Pharmaceutica Sinica, 2021 , 56 (3) : 661 -668 . DOI: 10.16438/j.0513-4870.2020-1633
Year 2021 volume 56 Issue 3
PDF
144
64
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-1633
  • Receive Date:2020-10-19
  • Online Date:2025-12-18
  • Published:2021-03-12
Article Data
Affiliations
History
  • Received:2020-10-19
  • Revised:2020-11-17
Funding
Affiliations
    Beijing Key Lab of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-1633
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT